Retour
Fourchette du Jour
9,75 €
11,36 €
Fourchette 52 Semaines
5,00 €
15,12 €
Volume
200
Moyenne 50J / 200J
10,76 €
/
11,34 €
Clôture Précédente
10,77 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -177,3 | 0,4 |
| P/B | 1,3 | 2,9 |
| ROE % | -0,7 | 3,7 |
| Net Margin % | -1,0 | 3,9 |
| Rev Growth 5Y % | 25,1 | 10,0 |
| D/E | 0,2 | 0,2 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2029 |
5,70 €
3,93 € – 9,22 €
|
41 B | 1 |
| FY2028 |
5,68 €
3,92 € – 9,19 €
|
32 B | 1 |
| FY2027 |
2,53 €
1,74 € – 4,09 €
|
22 B | 1 |
Points Clés
Revenue grew 25,12% annually over 5 years — strong growth
Debt/Equity of 0,22 — conservative balance sheet
Negative free cash flow of -418,39M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 26,70%
Croissance
Revenue Growth (5Y)
25,12%
Revenue (1Y)51,82%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-0,74%
ROIC-3,55%
Net Margin-1,00%
Op. Margin-8,02%
Sécurité
Debt / Equity
0,22
Current Ratio2,35
Interest Coverage-11,17
Valorisation
P/E Ratio
-177,30
P/B Ratio1,28
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 51,82% | Revenue Growth (3Y) | 43,80% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 25,12% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 9,42B | Net Income (TTM) | -94,63M |
| ROE | -0,74% | ROA | -0,44% |
| Gross Margin | 83,97% | Operating Margin | -8,02% |
| Net Margin | -1,00% | Free Cash Flow (TTM) | -418,39M |
| ROIC | -3,55% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,22 | Current Ratio | 2,35 |
| Interest Coverage | -11,17 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -177,30 | P/B Ratio | 1,28 |
| P/S Ratio | 1,78 | PEG Ratio | 6,00 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 16,78B | Enterprise Value | 12,10B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 9,42B | 6,21B | 4,56B | 4,27B | 3,84B |
| Net Income | -94,63M | -1,03B | -2,18B | -2,73B | -998,42M |
| EPS (Diluted) | -0,06 | -0,66 | -1,46 | -1,88 | -0,74 |
| Gross Profit | 7,91B | 4,40B | 3,63B | 3,70B | 3,46B |
| Operating Income | -755,87M | -1,68B | -3,12B | -2,70B | -557,19M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 21,60B | 20,63B | 17,59B | 16,24B | 11,83B |
| Total Liabilities | 8,48B | 8,10B | 6,86B | 5,91B | 3,06B |
| Shareholders' Equity | 13,12B | 12,53B | 10,73B | 10,33B | 8,78B |
| Total Debt | 2,83B | 3,62B | 3,23B | 2,50B | 1,21B |
| Cash & Equivalents | 7,51B | 10,05B | 1,02B | 1,36B | 1,28B |
| Current Assets | 10,27B | 13,43B | 11,51B | 11,55B | 9,47B |
| Current Liabilities | 4,37B | 4,48B | 3,50B | 3,05B | 1,49B |